Mutations in DNA damage responsepathways as a potentialbiomarker for immune checkpoint blockade efficacy: evidencefrom a seven-cancer immunotherapy cohort


原创 科技辣妈 桓峰基因 2022-05-22 20:41


https://mp.weixin.qq.com/s?__biz=MzU0NDY2NTUwOA==&mid=2247487166&idx=1&sn=34ecb878a14e4be7cd5f1d75edd06efc
--
FROM 59.41.66.*